AFT Pharmaceuticals Ltd (ASX:AFP)
A$ 2.55 -0.02 (-0.78%) Market Cap: 247.03 Mil Enterprise Value: 265.29 Mil PE Ratio: 18.46 PB Ratio: 3.31 GF Score: 88/100

Preliminary 2019 AFT Pharmaceuticals Ltd Earnings Call Transcript

May 21, 2019 / 10:00PM GMT
Release Date Price: A$2.4
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the AFT Pharmaceuticals Annual Results Analyst Briefing Conference Call. (Operator Instructions) I must advise you that this conference is being recorded today, Wednesday, the 22nd of May 2019.

I would now like to hand the conference over to your first speaker today, Dr. Hartley Atkinson, Chief Executive Officer of AFT Pharmaceuticals. Thank you, sir. Please go ahead.

Hartley Atkinson
AFT Pharmaceuticals Limited - Founder, CEO, MD & Executive Director

Okay. Thank you very much, and welcome, everyone, to our presentation of our 2019 results. There's a presentation deck, as I'm sure you can all see. So what we'd like to do is to go through the presentation deck page by page. It will be myself and Malcolm Tubby, who is our CFO. And then after, at the end of the deck, we will have time for questions.

So look, just to start, there's Page 1. As you can see, it's just the heading. And Page 2 is the standard disclaimers, important notice. So just to be aware of that. I won't bother

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot